161 related articles for article (PubMed ID: 31791173)
1. The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibody.
Masiero A; Nelly L; Marianne G; Christophe S; Florian L; Ronan C; Claire B; Cornelia Z; Grégoire B; Eric L; Ludovic L; Dominique B; Sylvie A; Marie G; Francis D; Fabienne S; Cécile C; Isabelle A; Jacques D; Jérôme D; Bruno G; Katarina R; Jean-Michel M; Catherine P
MAbs; 2020; 12(1):1698128. PubMed ID: 31791173
[TBL] [Abstract][Full Text] [Related]
2. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope.
Ofek G; Tang M; Sambor A; Katinger H; Mascola JR; Wyatt R; Kwong PD
J Virol; 2004 Oct; 78(19):10724-37. PubMed ID: 15367639
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.
Ofek G; Zirkle B; Yang Y; Zhu Z; McKee K; Zhang B; Chuang GY; Georgiev IS; O'Dell S; Doria-Rose N; Mascola JR; Dimitrov DS; Kwong PD
J Virol; 2014 Mar; 88(5):2426-41. PubMed ID: 24335316
[TBL] [Abstract][Full Text] [Related]
4. Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography.
Do Kwon Y; Wang XE; Bender MF; Yang R; Li Y; McKee K; Rawi R; O'Dell S; Schneck NA; Shaddeau A; Zhang B; Arnold FJ; Connors M; Doria-Rose NA; Kwong PD; Lei QP
Antibodies (Basel); 2021 Jun; 10(2):. PubMed ID: 34200826
[TBL] [Abstract][Full Text] [Related]
5. Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy.
O'Neal KD; Chari MV; Mcdonald CH; Cook RG; Yu-Lee LY; Morrisett JD; Shearer WT
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):833-44. PubMed ID: 8645165
[TBL] [Abstract][Full Text] [Related]
6. The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8.
Guttman M; Padte NN; Huang Y; Yu J; Rocklin GJ; Weitzner BD; Scian M; Ho DD; Lee KK
Sci Rep; 2020 Aug; 10(1):14313. PubMed ID: 32868832
[TBL] [Abstract][Full Text] [Related]
7. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.
Chen J; Frey G; Peng H; Rits-Volloch S; Garrity J; Seaman MS; Chen B
J Virol; 2014 Jan; 88(2):1249-58. PubMed ID: 24227838
[TBL] [Abstract][Full Text] [Related]
9. Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region.
Ofek G; McKee K; Yang Y; Yang ZY; Skinner J; Guenaga FJ; Wyatt R; Zwick MB; Nabel GJ; Mascola JR; Kwong PD
J Virol; 2010 Mar; 84(6):2955-62. PubMed ID: 20042512
[TBL] [Abstract][Full Text] [Related]
10. Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.
Julien JP; Huarte N; Maeso R; Taneva SG; Cunningham A; Nieva JL; Pai EF
J Virol; 2010 May; 84(9):4136-47. PubMed ID: 20147404
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
Kwon YD; Georgiev IS; Ofek G; Zhang B; Asokan M; Bailer RT; Bao A; Caruso W; Chen X; Choe M; Druz A; Ko SY; Louder MK; McKee K; O'Dell S; Pegu A; Rudicell RS; Shi W; Wang K; Yang Y; Alger M; Bender MF; Carlton K; Cooper JW; Blinn J; Eudailey J; Lloyd K; Parks R; Alam SM; Haynes BF; Padte NN; Yu J; Ho DD; Huang J; Connors M; Schwartz RM; Mascola JR; Kwong PD
J Virol; 2016 Jul; 90(13):5899-5914. PubMed ID: 27053554
[TBL] [Abstract][Full Text] [Related]
13. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
Zwick MB; Komori HK; Stanfield RL; Church S; Wang M; Parren PW; Kunert R; Katinger H; Wilson IA; Burton DR
J Virol; 2004 Mar; 78(6):3155-61. PubMed ID: 14990736
[TBL] [Abstract][Full Text] [Related]
14. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
[TBL] [Abstract][Full Text] [Related]
16. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
[TBL] [Abstract][Full Text] [Related]
17. Initiation of prolyl cis-trans isomerisation in the CDR-H3 loop of an antibody in response to antigen binding.
Shinoda K; Fujitani H
Sci Rep; 2017 Dec; 7(1):16964. PubMed ID: 29208911
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activity.
Yi M; Sun J; Sun H; Wang Y; Hou S; Jiang B; Xie Y; Ji R; Xue L; Ding X; Song X; Xu A; Huang C; Quan Q; Song J
MAbs; 2023; 15(1):2215364. PubMed ID: 37229604
[TBL] [Abstract][Full Text] [Related]
19. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
Julien JP; Bryson S; Nieva JL; Pai EF
J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
[TBL] [Abstract][Full Text] [Related]
20. Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.
Montgomery DL; Wang YJ; Hrin R; Luftig M; Su B; Miller MD; Wang F; Haytko P; Huang L; Vitelli S; Condra J; Liu X; Hampton R; Carfi A; Pessi A; Bianchi E; Joyce J; Lloyd C; Geleziunas R; Bramhill D; King VM; Finnefrock AC; Strohl W; An Z
MAbs; 2009; 1(5):462-74. PubMed ID: 20065653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
